This is the latest biotechnology vaccine at the molecular level. By using genetic engineering technology, the gene encoding the protective antigen is recombined with the vector DNA that can be expressed in eukaryotic cells. The recombinant DNA of the target gene and expression vector can be directly injected (inoculated) into animals (such as mice), and the target gene can be expressed in animals to stimulate the body to produce humoral immunity and cellular immunity.